The Epinephrine Autoinjector Market size was valued at USD 2.32 Billion in 2020 and is projected to reach USD 3.70 Billion by 2028, growing at a CAGR of 8% during the forecast period 2022 to 2028.
An epinephrine autoinjector is a medical device used to administer epinephrine or adrenaline to treat anaphylaxis. These are hand-held devices that contain a fixed dose of epinephrine and a spring-loaded needle that delivers the medication to a patient suffering from a severe allergic reaction or anaphylaxis. Epinephrine, also called adrenaline, is a neurotransmitter and hormone produced by the adrenal glands. Epinephrine can also be used as a drug due to its numerous important functions. This is a class of drugs called alpha-adrenergic agonists and beta-adrenergic agonists (sympathomimetic agents). It works by constricting the blood vessels and relaxing the muscles in the airways.
(Get 15% Discount on Buying this Report)
A full report of Global Epinephrine Autoinjector Market is available at: https://orionmarketreports.com/epinephrine-autoinjector-market/109444/
Market Segments
By Dosage
- 0.15mg Epinephrine Autoinjector
- 0.3mg Epinephrine Autoinjector
- 0.5mg Epinephrine Autoinjector
By Age Group
- Under 6 Years Patients
- 6 to 12 Years Patients
- Over 12 Years Patients
Key Players
- ALK-Abell A/S
- Impax Laboratories, Inc.
- Lincoln Medical Centre Ltd.
- Mylan N.V.
- Antares Pharma
- Adamis Pharmaceuticals Corporation
- Pfizer Inc.
- Kaleo, Inc.
- Teva Pharmaceutical Industries Ltd.
- Bausch & Lomb Incorporated
Scope of the Report
The research study analyzes the global Epinephrine Autoinjector industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Epinephrine Autoinjector Market Report
1. What was the Epinephrine Autoinjector Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Epinephrine Autoinjector Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Epinephrine Autoinjector Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Epinephrine Autoinjector market.
- The market share of the global Epinephrine Autoinjector market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Epinephrine Autoinjector market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Epinephrine Autoinjector market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
